Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor-Reference-Cited by-同舟云学术

Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor

Published:2024-05-21 Issue:11 Volume:51 Page:3322-3333
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Zhang Tao^ORCID,Ma Xinrui^ORCID,Xu Muyun^ORCID,Cai Jinghua,Cai Jianhua,Cao Yanguang,Zhang Zhihao,Ji Xin,He Jian,Cabrera German Oscar Fonseca,Wu Xuedan^ORCID,Zhao Weiling,Wu Zhanhong^ORCID,Xie Jin^ORCID,Li Zibo^ORCID

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00259-024-06754-2.pdf

Reference65 articles.

1. de Groot PM, Wu CC, Carter BW, Munden RF. The epidemiology of lung cancer. Transl Lung Cancer Res. 2018;7:220–33.

2. Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer Statistics. 2021. CA: A Cancer Journal for Clinicians. 2021;71:7–33.

3. White JF, Noinaj N, Shibata Y, et al. Structure of the agonist-bound neurotensin receptor. Nature. 2012;490:508–13.

4. Wu Z, Martinez-Fong D, Trédaniel J, Forgez P. Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy. Front Endocrinol (Lausanne). 2012;3:184.

5. Goedert M, Reeve JG, Emson PC, Bleehen NM. Neurotensin in human small cell lung carcinoma. Br J Cancer. 1984;50:179–83.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of⁶⁴Cu-,⁵⁵Co-, and⁶⁸Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles;Journal of Nuclear Medicine;2024-06-13